IV Compatibility: Cupric (Copper) and Zosyn (Piperacillin/Tazobactam)
Based on the FDA labeling for Zosyn, there is no documented compatibility data for cupric (copper) salts with piperacillin/tazobactam, and these medications should NOT be co-administered through the same IV line.
Key Compatibility Information from FDA Labeling
The Zosyn FDA label 1 explicitly states specific compatibility requirements:
- Do NOT add supplementary medication to ZOSYN Injection in GALAXY Containers
- ZOSYN containing EDTA is compatible for co-administration via Y-site only with:
- Lactated Ringer's injection
- Specific aminoglycosides (amikacin and gentamicin) under defined conditions
- 0.9% sodium chloride or 5% dextrose (as diluents)
Critical Compatibility Restrictions
The FDA labeling 1 provides an exhaustive list of what can be mixed with Zosyn. Cupric salts are conspicuously absent from this list, which is clinically significant because:
- The reformulated Zosyn contains EDTA (edetate disodium dihydrate) as a metal chelator 1
- EDTA is specifically designed to bind metal ions, including copper
- This chelation could lead to:
- Precipitation or particulate formation
- Inactivation of either medication
- Unpredictable drug concentrations
Clinical Recommendation
Administer cupric supplements and Zosyn through separate IV lines or at different times. If only one IV access is available:
- Flush the line thoroughly between medications with compatible solution (0.9% sodium chloride)
- Allow adequate time between administrations
- Consider alternative timing of trace element supplementation (e.g., during periods when Zosyn is not infusing)
Important Caveat
Research evidence 2 demonstrated that piperacillin/tazobactam was incompatible with 24 of 75 tested drugs, showing "increased turbidity, particulate formation and precipitation, and color change." Without specific compatibility testing for cupric salts, the risk of physical or chemical incompatibility is substantial and should be avoided.